Author

A. M. Prystrom

Observed name: A. M. Pristrom

Institution: Belarusian Medical Academy of Post-Graduate Education

Observed institution: Belarusian Medical Academy of Post-Graduate Education

ORCID: 0000-0002-5782-8832

Observed ORCID: 0000-0002-5782-8832

OpenAlex ID: A5017143127

Effectiveness and safety of levilimab in combination with methotrexate in treatment of patients with active rheumatoid arthritis resistant to methotrexate monotherapy (double-blinded randomized placebo controlled phase III clinical study SOLAR)

2021 · V. I. Mazurov, M. A. Korolev, et al. · Modern Rheumatology Journal · 14

Efficacy and Safety of Levilimab in Combination with Methotrexate in Patients with Active Rheumatoid Arthritis: 56-Week Results of Phase III Randomized Double-Blind Placebo-Controlled Trial SOLAR

2024 · V. I. Mazurov, E. L. Nasonov, et al. · Doklady Biochemistry and Biophysics · 5

Efficacy and safety of levilimab in combination with methotrexate in patients with active rheumatoid arthritis: 56-week results of phase III randomized double-blind placebo-controlled trial SOLAR

2023 · V. I. Mazurov, A. M. Lila, et al. · Rheumatology Science and Practice · 5

Comparative study of clinical efficacy of biosimilar Nektelisa (tenecteplase) based on randomized clinical trial

2025 · M. M. Agirov, I. E. Adzeriho, et al. · Russian Journal of Cardiology · 3

Predictors of Adverse Events in Pregnant Women With Deficiency of Body Weight

2023 · A. M. Prystrom, S. A. Hisamo · Journal of the Grodno State Medical University · 1

Slowing the progression of ankylosing spondylitis during long-term therapy with netakimab: results of the international multicenter randomized double-blind phase III clinical trial BCD-085-5/ASTERA

2025 · V. I. Mazurov, A. M. Lila, et al. · Modern Rheumatology Journal

Works count: 6

Citation count: 28

H-index: 3

I10-index: 1